Principles of Infectious Disease and Epidemiology: Study Notes

Principles of Infectious Disease and Epidemiology

9.1: Causes of Infectious Disease

Understanding infectious diseases requires familiarity with key terminology and concepts that form the foundation of modern healthcare and epidemiology.

• Infectious disease: Illness caused by a pathogen (disease-causing agent).

• Pathogens: Include prions, viruses, bacteria, protozoans, helminths, and fungi.

• Opportunistic pathogens: Cause disease only when the host is weakened (e.g., immunocompromised individuals).

• True pathogens: Can cause disease in healthy hosts (e.g., Treponema pallidum, the causative agent of syphilis).

• Epidemiology: The science of monitoring and controlling disease occurrence to promote public health.

Disease Occurrence Patterns

• Sporadic cases: Isolated infections in a population (e.g., plague in the U.S.).

• Endemic infections: Routinely detected in a population or region (e.g., cold viruses).

• Epidemic: Widespread outbreak in a region during a specific time (e.g., Ebola).

• Pandemic: Epidemic that spreads to multiple countries (e.g., 1918 flu, COVID-19).

Emerging and Reemerging Pathogens

• Emerging pathogens: Newly identified or previously rare agents (e.g., SARS-CoV-2, Zika virus).

• Reemerging pathogens: Previously controlled agents now resurfacing (e.g., antibiotic-resistant bacteria).

• ~60% of emerging diseases are zoonotic (spread from animals to humans).

Communicability

• Communicable diseases: Transmitted from human to human (e.g., syphilis).

• Contagious diseases: Easily transmitted between hosts (e.g., measles).

Describing Infections

• Signs: Objective, measurable indicators (e.g., fever, rash, lab results).

• Symptoms: Subjective experiences reported by the patient (e.g., pain, fatigue).

• Latent infections: Asymptomatic; no signs or symptoms present.

Onset and Duration

• Acute diseases: Rapid onset and progression (e.g., influenza).

• Chronic diseases: Slower onset and progression (e.g., HIV/AIDS).

9.2: Infectious Disease Transmission and Stages

Pathogens originate from various sources and are transmitted through different modes, leading to characteristic stages of disease progression.

Reservoirs and Sources

• Reservoir: Natural habitat (animate or inanimate) where a pathogen is found.

• Source: The immediate origin from which a pathogen is transmitted to a host.

• Endogenous source: Pathogen originates from the host's own body.

• Exogenous source: Pathogen is external to the host.

Modes of Transmission

• Direct contact: Physical contact with the source (e.g., bites, touching, kissing).

• Vertical transmission: Pathogen passes from mother to offspring (in utero, during delivery, or breastfeeding).

• Indirect contact: No direct physical contact; includes:

  • Airborne transmission: Inhalation of pathogen-laden droplets.

  • Vehicle transmission: Contact with contaminated objects (fomites) such as doorknobs, needles, food.

  • Vector transmission: Transmission via arthropods (e.g., mosquitoes, ticks); can be biological or mechanical.

Stages of Infectious Disease

• Incubation period: Time between infection and symptom onset (can range from hours to years).

• Prodromal phase: Mild, nonspecific symptoms appear.

• Acute phase: Full-blown, classical symptoms; may be symptomatic (clinical) or asymptomatic (subclinical).

• Period of decline: Pathogen replication decreases; patient begins to recover.

• Convalescent phase: Pathogen eliminated; recovery continues. Some hosts may become chronic or asymptomatic carriers (e.g., "Typhoid Mary").

Key Terms

• Infectivity: Ability of a pathogen to establish infection.

• Pathogenicity: Ability to cause disease.

• Virulence: Severity of disease caused.

9.3: Epidemiology Essentials

Epidemiology is the study of disease patterns in populations, aiming to understand, prevent, and control illness.

The Epidemiological Triangle

• Host: Individual or population at risk; factors include age, health, nutrition, immune status.

• Etiological agent: The causative pathogen (e.g., virus, bacterium, fungus, protozoan).

• Environment: External factors influencing disease transmission (e.g., climate, season, vector presence).

Disrupting any side of the triangle can help prevent disease spread.

Public Health Strategies

• Public education: Vaccination campaigns, prenatal care, STD education.

• Quarantine: Isolation of individuals to prevent spread; may be impractical for diseases with long incubation periods.

• Vector control: Reducing populations of disease-carrying arthropods (e.g., mosquitoes, ticks).

Measures of Disease Frequency

• Population: Defined group under study.

• Morbidity: Presence of disease in a population.

• Prevalence rate: Proportion of total cases in a population during a specific time.

Formula:

$\text{Prevalence rate} = \frac{\text{Total cases in a defined population during a given time}}{\text{Total people in the defined population during the same time}}$

• Incidence rate: Number of new cases in a defined population during a specific time frame.

• Duration: How long the infection lasts; longer duration and higher incidence increase prevalence.

9.5: Epidemiology in Clinical Settings

Clinical epidemiology focuses on preventing and controlling infections within healthcare environments.

Historical Example: Hand Washing

• Ignaz Semmelweis (1840s): Demonstrated that hand washing with chlorine bleach drastically reduced puerperal fever mortality in maternity wards.

Healthcare-Acquired Infections (HAIs)

• Definition: Infections acquired in healthcare settings, including those emerging up to 14 days post-discharge.

• Prevalence: 5–10% of acute care patients contract at least one HAI.

• Common sources: Contaminated medical devices, healthcare workers' hands.

• Common HAIs: Clostridioides difficile GI infections, catheter-associated UTIs, surgical wound infections, MRSA bacteremia, device-related bloodstream infections, ventilator-associated pneumonia.

• Common pathogens: Staphylococcus aureus, Escherichia coli, Clostridioides difficile, Pseudomonas aeruginosa (often antibiotic-resistant).

Prevention and Control

• Surveillance and monitoring: Infection control personnel track transmission patterns.

• Basic measures: Hand washing, personal protective equipment, environmental sanitization, equipment sterilization, limiting patient transport, single-use equipment, patient isolation.

• Aseptic technique: Critical for catheter and central line management.

• Superbug HAIs: Drug-resistant infections monitored by hospital microbiologists; susceptibility data guides treatment.

9.6: Surveillance, Eradication, & Ethics in Epidemiology

Surveillance programs, eradication efforts, and ethical considerations are central to modern epidemiology.

Surveillance Programs

• CDC: Develops surveillance recommendations, collects, and shares data.

• National Notifiable Diseases Surveillance System (NNDSS): Network for monitoring and reporting certain diseases; includes ~60 notifiable diseases.

• Case reporting: Diagnosed cases are documented and reported up the chain to the CDC.

• Other surveillance: Antibiotic resistance, HAIs, foodborne illnesses, bioterrorism.

• MMWR: CDC's Morbidity and Mortality Weekly Report provides updates and summaries.

Emerging and Reemerging Diseases

• Emerging diseases: New or newly identified infections (e.g., Ebola, HIV, H1N1, Zika, COVID-19).

• Contributing factors: Population crowding, poverty, tropical climates, wildlife, deforestation, urbanization.

• Reemerging diseases: Previously controlled, now increasing due to factors like antibiotic resistance and increased immunosuppressed populations.

Eradication

• Definition: Complete global elimination of a disease (e.g., smallpox in 1977).

• Factors aiding eradication: Easily identifiable, treatable, human-only transmission.

• Barriers: Long incubation, latent infections, multiple reservoirs, high mutation rates.

Ethical Issues in Epidemiology

• Historical abuses: Tuskegee syphilis experiment (1932–1972) violated informed consent and patient rights.

• Modern standards: Informed consent is essential; studies must not put participants at serious risk.

• Clinical trials: Stopped early if evidence of harm emerges.

Vaccination Ethics and Herd Immunity

• Herd immunity: Achieved when ~85% of the population is immune, protecting those who cannot be vaccinated (e.g., newborns, immunocompromised).

• Vaccine hesitancy: Unfounded fears have led to decreased vaccination rates and reemergence of diseases (e.g., measles).

• Public health policy: Some regions have revoked personal exemptions for school attendance to maintain herd immunity.

Table: Common Healthcare-Associated Infection (HAI) Pathogens

Pathogen	Type	Common HAI(s)	Antibiotic Resistance
Staphylococcus aureus	Bacterium	Wound infections, MRSA bacteremia	High (MRSA)
Escherichia coli	Bacterium	Urinary tract infections	Increasing
Clostridioides difficile	Bacterium	Gastrointestinal infections	Some strains resistant
Pseudomonas aeruginosa	Bacterium	Device-related bloodstream infections, pneumonia	High

Additional info: Table inferred and summarized from text references to common HAI pathogens and their resistance patterns.

Summary

• Infectious diseases are caused by a variety of pathogens and can be classified by their transmission, duration, and epidemiological patterns.

• Epidemiology provides tools and frameworks (e.g., the epidemiological triangle) for understanding and controlling disease spread.

• Public health strategies, surveillance, and ethical considerations are essential for disease prevention and control.

• Healthcare settings require rigorous infection control to prevent HAIs, especially those caused by antibiotic-resistant organisms.

• Vaccination and herd immunity are critical for protecting vulnerable populations and preventing disease resurgence.